Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

693 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum concentrations of leptin and insulin in men.
Zitzmann M, Gromoll J, von Eckardstein A, Nieschlag E. Zitzmann M, et al. Diabetologia. 2003 Jan;46(1):31-9. doi: 10.1007/s00125-002-0980-9. Epub 2002 Dec 20. Diabetologia. 2003. PMID: 12637980
The role of growth hormone and insulin-like growth factor I in the regulation of male reproductive function.
Spiteri-Grech J, Nieschlag E. Spiteri-Grech J, et al. Horm Res. 1992;38 Suppl 1:22-7. doi: 10.1159/000182566. Horm Res. 1992. PMID: 1295809 Review.
Using Leydig and Sertoli cell cultures, complex interactions between GH/IGF-I and the gonadotropins affecting differentiated cell functions, e.g. steroidogenesis and cell division, have been demonstrated at the cellular level. ...
Using Leydig and Sertoli cell cultures, complex interactions between GH/IGF-I and the gonadotropins affecting differentiated cell functions, …
Microheterogeneity of pituitary follicle-stimulating hormone in male rats: differential effects of the chronic androgen deprivation induced by castration or androgen blockade.
Simoni M, Weinbauer GF, Chandolia RK, Nieschlag E. Simoni M, et al. J Mol Endocrinol. 1992 Oct;9(2):175-82. doi: 10.1677/jme.0.0090175. J Mol Endocrinol. 1992. PMID: 1418388
Effective suppression of luteinizing hormone and testosterone by single doses of the new gonadotropin-releasing hormone antagonist cetrorelix (SB-75) in normal men.
Behre HM, Klein B, Steinmeyer E, McGregor GP, Voigt K, Nieschlag E. Behre HM, et al. J Clin Endocrinol Metab. 1992 Aug;75(2):393-8. doi: 10.1210/jcem.75.2.1639941. J Clin Endocrinol Metab. 1992. PMID: 1639941 Clinical Trial.
Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
Behre HM, Nashan D, Hubert W, Nieschlag E. Behre HM, et al. J Clin Endocrinol Metab. 1992 Jan;74(1):84-90. doi: 10.1210/jcem.74.1.1727833. J Clin Endocrinol Metab. 1992. PMID: 1727833 Clinical Trial.
Comparative effects of chronic administration of the non-steroidal antiandrogens flutamide and Casodex on the reproductive system of the adult male rat.
Chandolia RK, Weinbauer GF, Simoni M, Behre HM, Nieschlag E. Chandolia RK, et al. Acta Endocrinol (Copenh). 1991 Nov;125(5):547-55. doi: 10.1530/acta.0.1250547. Acta Endocrinol (Copenh). 1991. PMID: 1759544
Effects of flutamide on testicular involution induced by an antagonist of gonadotrophin-releasing hormone and on stimulation of spermatogenesis by follicle-stimulating hormone in rats.
Chandolia RK, Weinbauer GF, Fingscheidt U, Bartlett JM, Nieschlag E. Chandolia RK, et al. J Reprod Fertil. 1991 Nov;93(2):313-23. doi: 10.1530/jrf.0.0930313. J Reprod Fertil. 1991. PMID: 1787450
Human follicle-stimulating hormone exerts a stimulatory effect on spermatogenesis, testicular size, and serum inhibin levels in the gonadotropin-releasing hormone antagonist-treated nonhuman primate (Macaca fascicularis).
Weinbauer GF, Behre HM, Fingscheidt U, Nieschlag E. Weinbauer GF, et al. Endocrinology. 1991 Oct;129(4):1831-9. doi: 10.1210/endo-129-4-1831. Endocrinology. 1991. PMID: 1915071
693 results
Jump to page
Feedback